Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You obviously don't care about Fundamentals.
Take a look at the market cap, it's a lot lower than all of their assets, and they have their debt taken care of now.
Technicals are way more important because they tell you your entry and exit.
n2bugs, you are correct that now is good time to flip. This is consolidation though, and during consolidation is the right time to flip and stuff.
My advice? Hold a core position for when this retests 7.5 cents, and eventually breaks it to fill a huge gap to .12 - .18 - .30.
Keep flipping, your core shares will be free pretty quickly and pretty easy, since it is clear you know what you're doing in the market.
GLTA
You mean, overbought.
Count your zeros man, 40,000. 40 grand.
t 0.05 20000 OBB 16:01:08
t 0.05 10000 OBB 16:01:06
t 0.0488 10000 OBB 16:01:04
0.05 10000 OBB 15:59:08
0.0495 1200 OBB 15:58:32
0.0495 19702 OBB 15:58:32
0.049 80298 OBB 15:58:27
0.049 20000 OBB 15:57:44
0.049 19700 OBB 15:56:29
0.0485 64200 OBB 15:56:23
0.049 100000 OBB 15:56:19
0.049 50000 OBB 15:55:43
0.049 40000 OBB 15:55:24
0.049 12000 OBB 15:55:24
0.0489 100000 OBB 15:55:19
0.0485 19000 OBB 15:55:10
0.0485 20000 OBB 15:53:28
0.0485 75000 OBB 15:52:43
0.0485 85000 OBB 15:52:43
0.0485 100000 OBB 15:52:18
0.048 5000 OBB 15:50:33
0.048 19000 OBB 15:47:31
I agree with your complaint, but at least your complaint has absolutely nothing to do with share price or the company and their product. It also has nothing to do with the biotech sector and their share prices.
So at least our trading will not be affected AT ALL! :)
GLTA
GREAT POST From Yahoo Boards about BGOI!
http://messages.finance.yahoo.com/Business_%26_Finance/Investments/Stocks_%28A_to_Z%29/Stocks_B/threadview?bn=77515&tid=211&mid=211
Not until the outstanding share count approaches anything CLOSE to our authorized share count.
Outstanding Shares: 200,000,000
Authorized Shares: 6,000,000,000
A reverse split is not on the horizon. Maybe this time next year.
www.otcbb.com take a look! .2852! level II BGOI now that its been 20 minutes, you can see the trade for yourself.
t 0.2852 100000 OBB 16:08:36
t 0.0596 500000 OBB 16:02:10
t 0.061 25000 OBB 16:00:54
t 0.062 25000 OBB 16:00:46
0.062 10000 OBB 15:59:56
0.062 10000 OBB 15:59:33
0.062 10000 OBB 15:59:16
0.062 45000 OBB 15:59:02
0.062 23800 OBB 15:58:57
0.062 1200 OBB 15:58:55
0.061 4500 OBB 15:57:45
0.061 8200 OBB 15:57:37
0.06 11623 OBB 15:57:33
0.061 20000 OBB 15:57:33
0.06 10000 OBB 15:57:20
0.061 100 OBB 15:57:00
0.06 5000 OBB 15:53:34
0.06 12000 OBB 15:53:31
0.06 10000 OBB 15:52:29
0.06 50000 OBB 15:51:42
0.0595 85000 OBB 15:50:27
0.06 8000 OBB 15:48:48
0.06 5000 OBB 15:48:40
0.06 33000 OBB 15:48:40
0.061 44000 OBB 15:48:23
0.06 50000 OBB 15:48:22
0.06 50000 OBB 15:48:00
0.06 100000 OBB 15:48:00
0.06 73000 OBB 15:47:24
0.0605 3000 OBB 15:47:20
I Uploaded the $0.2852 trade for you.
It is a screen shot of my Scottrade Elite's Level II.
Look at the bottom right. The one and only trade after the 4:05 news.
http://www.mediafire.com/imageview.php?quickkey=oejwxt0jxy5&thumb=6
SOMEONE PLEASE EXPLAIN 100K SHARES @ $0.2852
Form T (obviously by an MM) at 16:08:41 ... that was 3 minutes after the news, and it was the only trade since the news...
Are we seriously heading to .30?
its in one of the conference calls. i dont know what he means with taxatere and .10 a share, but ray did say independant auditors said 50% > chance of overall survival being good.
Yes I understand the PR was not partnership news, but it is that they hired an agency in South Korea to speed things up and partner Tesetaxel out there for them. Think they can get it done by Feb 8-10 Conference?
CBrad, your posts suggests that Genta is being sketchy because they are trying to partner in South Korea instead of in the USA.
http://www.worldmapper.org/display_extra.php?selected=421
They would be idiots NOT to Partner in Asia, CBrad...come on now.
What's that? Genta won't be going subpenny anytime soon?
Wow, Smitter, what do you think of that? I mean, I knew it wouldn't go subpenny, on October 29th. I just want to know what you and everyone else thinks about this now that you have no shares anywhere near the price you thought it was going to go.
I only have 5500 left out of my 7000.
GLTA
Smitter is correct.
The new 50 mil has not kicked in yet. This is because there has yet to be financing assigned to that 50 million dollars worth of registered shares.
Smitter, If you feel so strongly about Genta going to sub-penny, then I ask, do you have a short position in Genta? You would make a KILLING if this went to subpenny. I have 0 shares of Genta shorted, as I think we will head to .50 and higher in the coming month(s)
Smitter,
Firstly, it's been a while. Hope you've been good, and as always, thanks for keeping the iBox looking nice
I came here to answer the question of "What news could make the PPS go up?" and I said financing. I was immediately "knocked" by STL and Bubblebang for this...but I thought them "knocking" me was just good arguing...
I didn't LIE when I said you were wrong about AGENDA. Surely I am wrong about AGENDA too, I didn't sell once and I still have the same 7k shares as I did when I bought at .37.
I also didn't LIE when I said you and the board were speaking of sub-penny as if it were sketched in stone. Usually when someone "knocks" someone it is the equivalent to "talking sh!t about them", and in order to talk crap about someone, you have to make up lies. You know, crap = lies. I didn't lie in any of my posts, and I would hope that you could defend yourself better than telling me to shut up...I'm here to talk about stocks and didn't "knock" you at all, sir.
PPS is all that matters. You don't think that when GENTA announces that they are not going to go bankrupt and they will live another x amount of months...that the PPS won't go up? Come on now. Smitter and this board was wrong about AGENDA and spoke of it as a sure thing. Now, Smitter keeps talking about sub-penny as if it is written in stone. BK is the only thing that will bring this stock subpenny in Q1 2010.
Hi bubblebang, i think it is quite obvious that we are all referring to the financing that will allow the company to survive past the end of jan/feb, when talking about "impending news from this company would cause the PPS to go up"
STLCardinalsFan: Link to Genta 2010 Financing equaling dilution???
And most publicly traded companies go through dilution, but i think me and you are both referring to toxic financing like issuing 1 billion shares at .002 when the price of the stock is .01 like they did back in april-july.
So again, do you have a link the proves that the 2010 Financing of Genta is going to be toxic financing? Of course you don't.
Financing
Good thing I'm not one of those idiots who thinks that that is the float, (you said "If you think there's only 2 million shares in the float you're an idiot")
because...
THOSE NUMBERS ARE FROM DECEMBER 16 AND THE RUN WAS AFTER THAT....
all of those sells happened AFTER. Those sells that you are referring to arent reflected in the data in the S1/A. The actual float is unknown, but before the run, according to the new S1/A the float was just under 3 million the night before the run. And if that's wrong, then genta lied to the SEC.
NEW S1/A! EXTREMELY LOW FLOAT!!!!
http://www.sec.gov/Archives/edgar/data/880643/000114420409065684/v169513_s1a.htm
"The closing price of our common stock on the OTC Bulletin Board on December 16, 2009 was $0.08 per share. There were 120 holders of record of our common stock as of December 16, 2009. We estimate that there are approximately 19,250 beneficial owners of our common stock."
Shares Outstanding as of December 16, 2009: 191,810,882
Shares Owned by Genta Officials (Ray) and all of the Financers (BAM, Cat, etc.): 189,000,960
THAT MEANS THE FLOAT IS: 2,809,922
So...if me and my friends/family who invested have around 75,000 shares...that means that...ME AND MY FAMILY OWN JUST UNDER 3% OF THE FLOAT!? WTF!?!?!?!?
This is extremely interesting. Holding....
Reverse split
Lazard Webcast Highlights 11/18/09 3:15PM
FINANCES
-------------
At the end of Q3, they had $7.4M in cash/short term investments.
Their projected burn rate per month is approx. $1.5M.
PIPELINE
-------------
Presented in this order:
Tesetaxel
-------------
Ray had a lot of great things to say about Tesetaxel. One thing he said something along the lines of "and with a partner we will be able to knock Docetaxel out of the race."
Worldwide Potential Revenue: $1.3 Billion
G4544 - Oral Gallium Compound
-------------
Ray showed another slide here about the potential revenue worldwide after saying good things about the company.
Worldwide Potential Revenue: $2.1 Billion
Genasense
-------------
Durable Response is more than 6 months "too early to tell"
Overall Survival is 9-12 months "too early to tell"
Ray said that the Independent Data Monitoring Board ran a very strict futility analysis where they requested only the possibility of statistical significance, with a Conditional Power greater than 50%, with a hazard ratio of 0.69. They passed this futility analysis and the DMB recommends that AGENDA be completed for Overall Survival data.
TIMELINE
-------------
AGENDA OS Futility Analysis - Q4 2009 (We just went over this)
Genasense: Short IV infusion melanoma trial - Q4 2009, Ray said that they are presenting this data in Berlin this weekend, and that they had...i think the word was "spectacular"...results. He also talked about the drug being Active in CLL and NHL.
Initiate: Weekly Tesetaxel Study - Q1 2010
Initiate: Phase 2b confirmatory gastric study - Q1 2010
Initiate: Phase 2a melanoma study - Q1 2010
Initiate: Phase 2a prostate cancer study - Q2 2010
AGENDA Overal Survival Analysis - Second Half of 2010
Then he closed the conference call by saying how they need funding to get through all of this, and that the funding is taking place "at this conference as we speak."
GLTA. Looks like financing should be announced soon.
http://www.genta.com/investor%20relations/pressreleases2.php?v=4&option=com_content&task=view&id=60&Itemid=&CID=454&SHID=&COID=
Beyond Candlesticks came out in 1994 and the other one (japenese charting techniques) came out in 2001.
Which is it that I should get? you just said beyond candlesticks gave an overview of the first, but that is the first.
EDIT: Maybe I'm wrong...maybe there is a third book taht i didn't mention, that you are referring to.
@Sakata
Which book do I get for the Candlestick Techniques? They are both by Steve Nison
Japanese Candlestick Charting Techniques, Second Edition (Hardcover) http://www.amazon.com/Japanese-Candlestick-Charting-Techniques-Second/dp/0735201811/ref=sr_1_1?ie=UTF8&s=books&qid=1258139180&sr=8-1
Beyond Candlesticks: New Japanese Charting Techniques Revealed (Wiley Finance) (Hardcover) http://www.amazon.com/Beyond-Candlesticks-Japanese-Charting-Techniques/dp/047100720X/ref=sr_1_7?ie=UTF8&s=books&qid=1258139180&sr=8-7
Good luck next week everyone if you hold shares of GETA still!
You still have your position Sakata? Could you go on Yahoo messenger please? Haven't got a chance to talk to you since D-Day happened.
sorry bernie, lol
i don't mean to bother you, but i was hoping to hear a reply to some of those emails before the market opens in the morning.
thanks! :) and good luck to you this week in investing, lets hope we finish green in whatever it is we all invest
ATG Study
Abraxane helped more than without it.
What if these results are the knock em dead results that we were looking for from AGENDA?
I'm NOT implying that they will be knock em dead, I just want to know what would happen to PPS and the value of Genasense for partnership purposes, if either of these two OTHER clinical trials are knock em dead.
I appreciate all answers.
I dunno. I would assume that Ray would partner still but just at a lower price.
It's either something odd smitter, or they just plain screwed up.
like, Ray promised AGENDA would be A+. GM301 was B+, and Mid Term only ended up being an A-.
He missed...didn't he?
i know what you mean...tang...baker...RAY...doesn't make sense...
Yeah I always thought it was real
Seriously Sakata? How so?
Haha, no, I know what's going on. Maybe it was wishful thinking that he was going to buy in the .50s....but he said in September, once we got to 1$ and more, he said it would retreat to .66
I mean its the 50ma, it makes sense.
I don't think it will retreat to the 200ma like Bundles says
I'm not friendly with Bundles, but I certainly don't think he is a paid basher. He said that the stock would retreat to .66 about a month ago, and thats where he would buy back in.
How is that bashing? He was correct about the stock...just look at the charts...we've retreated to the bottom of the bollinger bands and the 50ma. Nothing is wrong here.
Smitter knows more about the current O/S and how much has been converted and when....If you say 75mil is the rest then yeah I guess in the 180s or something???
debt is locked up so there will not be more than around 250M shares outstanding by the end of 2009
nutriman has the link to that, i have misplaced it. it should be in smitter's ibox but its not
.65 to .67 is the absolute lowest this will get imho. it's a matter of cents. if you're asking me, i'd just make your position now, its pretty damn cheap as it is.
Genta in November - Going Forward
October 26, 2009.
We are finally here. This is the last week of October, and November is going to be a crazy month. We are waiting for the release of AGENDA, of course, Genta’s confirmatory Phase III Trial that imho will have outstanding results with the PFS data. Along with this trial, Genta will be releasing the NYU study, as well as another trial. They will be presenting these at four different conferences in November. The first, is on November 12th, 2009, in New York. The other three take place after in Germany.
This means that AGENDA will be released by November 12th the very latest, obviously, since it is a topic of discussion at that conference.
Along with this they have stated that they will be filing for EMEA approval. They also are going to wrap up the rest of this drug with the new dosage and release that as well.
Along with this, they have a 14 day clause in the SEC filling that states that they can keep financing out of the public eye for 14 days after the release of AGENDA. They can tell no one except “the financers” what they are doing. Baker Bros, Tang, Ray, Itri, etc.
One would be led to believe that if the results are in fact as perfect as can be, that they will be seeking out one or more partnerships for Genasense, as Ray has already said these talks have begun. He has stated that the valuation of Genasense will become clear once the trials are released to the public. Ray has also talked about Tesetaxel partnerships possibly coming in Q4 as well.
So it shapes up to be a great month. This week, we’re certainly looking to make a move back over .80, and I hope we start the move back over $1 sooner rather than later.
My guess for AGENDA is November 3rd.
And don’t forget the Earnings will be out as well. There will be a conference call within the next four weeks imho.
Don’t listen to the message board users that say that AGENDA is going to be bad SOLELY based on the fact that the company hasn’t said anything yet. They don’t have to say anything. No news is good news. If AGENDA was bad (and its been unblinded for a MONTH now), then they would have put out PRs that said “We are very optimistic about a Tesetaxel partnership”.
IMHO, the data is knock-em dead. Long and strong with just under 7k shares. GLTA